March 27, 2020 Merck’s cough success highlights pipeline hopes Good news for patients whose cough is not caused by Covid-19: Merck’s chronic cough pill is a step closer to market. But tolerability questions remain.
April 16, 2019 US shutdown dampens first-quarter flotations Biopharma IPOs dipped in the opening months of 2019, but numbers look fairly healthy despite January's US government closure.
